Where Does Wall Street Think Corbus Pharmaceuticals Holdings Inc (CRBP) Stock Will Go?

Thursday, January 19, 2023 03:59 PM | InvestorsObserver Analysts

Mentioned in this article

InvestorsObserver is giving Corbus Pharmaceuticals Holdings Inc (CRBP) an Analyst Rating Rank of 26, meaning CRBP is ranked higher by analysts than 26% of stocks. The average price target for CRBP is $3 and analyst’s rate the stock as a Buy.

Wall Street analysts are rating CRBP a Buy today. Find out what this means to you and get the rest of the rankings on CRBP!
See Full CRBP Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Corbus Pharmaceuticals Holdings Inc Stock Today?

Corbus Pharmaceuticals Holdings Inc (CRBP) stock is unmoved -1.09% while the S&P 500 has fallen -0.57% as of 3:45 PM on Thursday, Jan 19. CRBP is flat $0.00 from the previous closing price of $0.14 on volume of 891,418 shares. Over the past year the S&P 500 is lower by -13.81% while CRBP has fallen -72.55%. CRBP lost -$0.33 per share the over the last 12 months. Click Here to get the full Stock Report for Corbus Pharmaceuticals Holdings Inc stock.

Share this article:

Related Articles